web analytics
Drug formulation development expanded by partnership with Vindonwestech | Velesco Pharma


velesco logo pms coa 405131 lc2 copy




Gerry Cox




(Plymouth, MI; April 28, 2011) - Velesco has boosted its drug formulation development program and clinical trial manufacturing services by partnering with Vindonwestech, Inc. Velesco, founded by ex-Pfizer scientists, offers expertise in analytical chemistry, pharmaceutical formulation and cGMP clinical supply manufacture, providing a perfect marriage with Vindonwestech’s stability storage services. With the experience and skill both organizations bring to the table in their respective fields, this partnership is to provide a level of focus, attention and the breadth of services that drug development programs require to succeed.


Velesco supports early stage drug development projects with a deeply experienced scientific team. Velesco is a CMC CRO, founded and staffed by pharmaceutical scientists with decades of experience in the industry. The company has two locations in Plymouth and Kalamazoo, MI.


Velesco provides fast and cost effective contract analytical development and drug formulation services along with cGMP clinical supplies for phase 1 and 2 clinical trials offering a full range of non-sterile dosage forms. The Velesco team offers personalized project management, state-of-the-art facilities and an experienced laboratory staff leading to comprehensive research relationships.


Vindonwestech, Inc. provides a full range of services, for both CROs and pharmaceutical manufacturers, to facilitate the cGMP storage of biological and pharmaceutical materials over a wide array of temperature and humidity. With over 15 years of stability/bio storage experience Vindon Scientific, parent company of Vindonwestech, has invested in a storage suite in the U.S. to meet the increasing demand for long term storage of pharmaceuticals.


Vindonwestech also designs, manufactures and installs a wide range of standard and custom controlled environment room systems, validated to meet the demanding requirements of the pharmaceutical, medical, biological and healthcare industries.


Patrick Jackson, Director of Vindon commented, “Vindonwestech is pleased to be associated with Velesco as Vindonwestech is particularly committed to providing storage services and equipment strengthening Velesco’s ability to deliver a first class stability program.” Shirley Smith, Quality Assurance Director at Velesco noted, “the Vindonwestech facility is impressively designed and equipped. A Velesco and Vindonwestech collaboration assures a strong cGMP quality program and clients can be confident their clinical trial materials will exceed FDA compliance requirements.”


About Velesco Pharmaceutical Services

Velesco was formed by former pharmaceutical R&D colleagues and focuses on supporting early stage drug development. Velesco’s founders, analytical chemists and drug formulation experts are pharmaceutical industry veterans working in the highest-quality facilities. Velesco delivers on time high quality products and services along with insightful consultation.


About Vindonwestech, Inc.

Vindonwestech, Inc. designs, manufactures and distributes high quality equipment and services to the pharmaceutical research, manufacturing and healthcare markets. Our environmental products provide controlled temperature and humidity conditions and range from small bench top cabinets to large purpose built rooms. Our systems are designed to meet the most rigorous of customer requirements while providing temperature and humidity control where precision is a principal component.

News and Events

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Read the Press Release!

Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.

View Recording!

Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.

Roundtable: M&A trends in CDMO - Molecule to Market

New Velesco Pharma clinical manufacturing facility begins operations.

Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.

Read the interview here.

Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.

Read the press release here.

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!

1 new job postings! Careers

Velesco's work published

Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.

Follow Velesco

LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter FB FindUsOnFacebook 100